biometric research branch activities in dna microarray investigations division of cancer diagnosis...
Post on 18-Dec-2015
215 views
TRANSCRIPT
![Page 1: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/1.jpg)
Biometric Research Branch Activities in DNA Microarray
InvestigationsDivision of Cancer Diagnosis and Treatment
National Cancer Institute
Richard Simon, D.Sc., Chief
http://linus.nci.nih.gov/brb
![Page 2: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/2.jpg)
DNA Microarray Technology
• Powerful tools for understanding mechanisms and enabling predictive medicine
• Challenges ability of biomedical scientists to analyze and interpret data
• Challenges mathematical scientists with new problems for which existing analysis paradigms are often inapplicable
![Page 3: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/3.jpg)
Difficulties Resulting from Inadequate Training and Organization for 21st Century
Biomedicine
• Hype• Excessive skepticism and inappropriate criticism• Mis-information
– Amature statisticians– Professional statisticians not sufficiently involved in
collaborative studies• Software that encourages invalid analysis
– Developed by individuals who don’t know enough about statistical analysis of high dimensional data
– Funded by decision makers who are floundering about how to organize to achieve the potential of bioinformatics and computational biology
![Page 4: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/4.jpg)
![Page 5: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/5.jpg)
![Page 6: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/6.jpg)
Involvement of Biometric Research Branch
• Developmental Diagnostics Working Group• Courses in genomics
– Biotechnology techniques (18 hrs lecture/20 hrs lab)
– Recombinant DNA methodology I (18/20)
– Advanced genome analysis (18/20)
– DNA binding proteins and transcriptional regulators (18/20)
– Cellular & molecular approaches to the study of cancer (18/20)
– Cold Spring Harbor Course in Computational Genomics
• Collaborations with Jeff Trent’s Laboratory of Cancer Genetics
• Establishment of Molecular Statistics & Bioinformatics Section
![Page 7: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/7.jpg)
• Collaborative research
• Methodological research
• Software development– MadB– BRB-ArrayTools
• Training– BRB post-docs– CCR scientists
![Page 8: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/8.jpg)
BRB Collaboration with CCR on Microarray based Investigations
• Joanna Shih, Ph.D.– Available for collaboration with CCR scientists
on the analysis of genomic data (including micro-array analysis). Has supervised 2 post-docs working jointly with BRB & CCR
• George Wright, Ph.D.– Collaborates intensively with Dr. Lou Staudt’s
Laboratory and is the primary statistician in the Lymphoma Leukemia Molecular Profiling Project (LLMPP).
![Page 9: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/9.jpg)
Other BRB Staff Collaboration in Microarray Studies
• Dr Paul Albert, serves as primary statistician for Urologic-oncology, Neuro-oncology, Pathology, Radiation oncology, Prevention, Metabolism branches
• Dr. Dodd, Korn, McShane, Zhao & post-docs – No obligations to intramural program, but collaborate on selected
studies, e.g. – With A Hildesheim, Rose Yang, Sophia Wang on gene
disregulation in Nasal pharyngeal carcinoma and the mechanism of HPV carcinogenesis in cervical cancer
– With T Ried, M Difilippantonio on whole genome expression and CGH analysis of human rectal carcinoma
![Page 10: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/10.jpg)
Collaboration with CCR on Microarray Studies
• Rich Simon– Sandy Swain (human breast cancer)– Xin Wang (human hepatocellular cancer)– Jeff Green (mouse models of breast cancer)– Ed Liu, Rick Klausner, Marston Linnehan,
Lanny Kirsh– Numerous consultations, eg Curt Harris,
Snorri Thorgeirsson, Steve Zeichner, Pat Steeg, Howard Fine,…
![Page 11: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/11.jpg)
![Page 12: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/12.jpg)
![Page 13: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/13.jpg)
![Page 14: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/14.jpg)
![Page 15: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/15.jpg)
![Page 16: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/16.jpg)
Classes & Workshops by BRB on Analysis of DNA Microarray
Expression Profile Data
• Monthly 4 hr class on statistical analysis of expression profiling data
• Monthly 4 hr class on BRB-ArrayTools software
• Full day workshops in which BRB statisticians consult with investigators on design and analysis of genomic data
![Page 17: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/17.jpg)
![Page 18: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/18.jpg)
Use of BRB Website for Education of Biomedical Scientists
http://linus.nci.nih.gov/brb
• Reprints & Technical Reports• Powerpoint presentations
– Audio files
• BRB-ArrayTools software– Message board
• BRB-ArrayTools Data Archive• Sample Size Planning for Targeted Clinical
Trials
![Page 19: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/19.jpg)
![Page 20: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/20.jpg)
![Page 21: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/21.jpg)
DNA Microarray Methodology• Simon R, Korn E, McShane L, Radmacher M, Wright G, Zhao Y. Design
and analysis of DNA microarray investigations, Springer-Verlag, 2004
• Simon R, Radmacher MD, Dobbin K. Design of studies with DNA microarrays. Genetic Epidemiology 23:21-36, 2002
• McShane LM, Radmacher MD, Freidlin B, Yu R, Li MC, Simon R. Methods of assessing reproducibility of clustering patterns observed in analyses of microarray data. Bioinformatics 18:1462-1469, 2002
• Korn EL, McShane LM, Troendle JF, Rosenwald A and Simon R. Identifying pre-post chemotherapy differences in gene expression in breast tumors: a statistical method appropriate for this aim. British Journal of Cancer 86:1093-1096, 2002
• Radmacher MD, McShane LM and Simon R. A paradigm for class prediction using gene expression profiles. Journal of Computational Biology 9:505-511, 2002.
• Simon R, Radmacher MD, Dobbin K, McShane LM. Pitfalls in the analysis of DNA microarray data. Journal of the National Cancer Institute 95:14-18, 2003.
![Page 22: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/22.jpg)
• Wright G, Simon R. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19:2448-55, 2003
• Simon R. Using DNA microarrays for diagnostic and prognostic prediction, Expert Review of Molecular Diagnostics 3(5) 587-595, 2003
• Simon R. Diagnostic and prognostic prediction using gene expression profiles in high dimensional microarray data, British J Cancer 89:1599-1604, 2003
• Korn EL, Troendle JF, McShane LM, Simon R.Controlling the number of false discoveries. Journal of Statistical Planning and Inference 124:379-08, 2004
• Molinaro A, Simon R, Pfeiffer R. Prediction error estimation: A comparison of resampling methods. Bioinformatics 21:3301-7,2005.
• Varma S, Simon R. Bias in error estimation when using cross-validation for model selection. BMC Bioinformatics 7:91, 2006.
![Page 23: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/23.jpg)
• Dobbin K, Shih J, Simon R. Questions and answers on design of dual-label microarrays for identifying differentially expressed genes. Journal of the National Cancer Institute 95:1362-69, 2003
• Dobbin K, Shih J, Simon R. Statistical design of reverse dye microarrays. Bioinformatics 19:803-810, 2003
• Dobbin K, Simon R. Comparison of microarray designs for class comparison and class discovery, Bioinformatics 18:1462-69, 2002; 19:803-810, 2003; 21:2430-37, 2005; 21:2803-4, 2005
• Dobbin K and Simon R. Sample size determination in microarray experiments for class comparison and prognostic classification. Biostatistics 6:27-38, 2005
• Dobbin K, Beer DG, Meyerson M, et al. Inter-laboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. Clinical Cancer Research 11:565-572, 2005
• Dobbin KK, Kawasaki ES, Petersen DW, and Simon RM. Characterizing dye bias in microarray experiments. Bioinformatics 21:2430-37, 2005
• Dobbin K and Simon R. Experimental design of DNA microarray studies. Encyclopedia of Genetics, Genomics, Proteomics and Bioinformatics. (L Jorde, P Little, M Dunn & S Subramaniam, eds). Wiley, 2005
• Dobbin K and Simon R. Sample size planning for developing classifiers using high dimensional DNA microarray data. Biostatistics (In Press).
![Page 24: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/24.jpg)
•Simon R and Maitnourim A. Evaluating the efficiency of targeted designs for randomized clinical trials. Clinical Cancer Research 10:6759-63, 2004.
•Maitnourim A and Simon R. On the efficiency of targeted clinical trials. Statistics in Medicine 24:329-339, 2005.
•Simon R. When is a genomic classifier ready for prime time? Nature Clinical Practice – Oncology 1:4-5, 2004.
•Simon R. An agenda for Clinical Trials: clinical trials in the genomic era. Clinical Trials 1:468-470, 2004.
•Simon R. Development and Validation of Therapeutically Relevant Multi-gene Biomarker Classifiers. Journal of the National Cancer Institute 97:866-867, 2005.
•Simon R. A roadmap for developing and validating therapeutically relevant genomic classifiers. Journal of Clinical Oncology 23:7332-41,2005.
•Freidlin B and Simon R. Adaptive signature design. Clinical Cancer Research 11:7872-78, 2005.
•Simon R. Validation of pharmacogenomic biomarker classifiers for treatment selection. Disease Markers (In Press).
•Simon R. Guidelines for the design of clinical studies for development and validation of therapeutically relevant biomarkers and biomarker classification systems. In Biomarkers in Breast Cancer, Hayes DF and Gasparini G, pp 3-15, Humana Press, 2006.
Using Genomic Classifiers In Clinical Trials
![Page 25: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/25.jpg)
• Simon R. and Wang SJ. Use of genomic signatures in therapeutics development in oncology and other diseases, The Pharmacogenomics Journal 6:166-73, 2006.
• Simon R. A checklist for evaluating reports of expression profiling for treatment selection. Clinical Advances in Hematology and Oncology 4:219-224, 2006.
• Trepicchio WL, Essayan D, Hall ST, Schechter G, Tezak Z, Wang SJ, Weinreich D, Simon R. Designing prospective clinical pharmacogenomic trials- Effective use of genomic biomarkers for use in clinical decision-
making. The Pharmacogenomics Journal 6:89-94,2006. • Dupuy A and Simon R. Critical review of published microarray studies for cancer outcome and guidelines on
statistical analysis and reporting, (Submitted for publication).
Using Genomic Classifiers In Clinical Trials
![Page 26: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/26.jpg)
BRB Websitehttp://linus.nci.nih.gov/brb
• 15,000 hits per month
• 702 hits to Technical Reports & Talks
• 1985 hits to BRB-ArrayTools home page
![Page 27: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/27.jpg)
BRB-ArrayTools
• Statistically state-of-the-art integrated software for DNA microarray data analysis– Architecture and statistical content by R Simon– Programming by contractor
• User interface for use and education of biomedical scientists
• Publicly available for non-commercial use• Active user list-serve and message board
http://linus.nci.nih.gov/brb
![Page 28: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/28.jpg)
BRB-ArrayToolsJune 2006
• 6283 Registered users• 2000+ Distinct institutions • 62 Countries• 245 Citations
• Registered users– 3528 in US– 456 at NIH– 246 at NCI
![Page 29: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/29.jpg)
![Page 30: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/30.jpg)
![Page 31: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/31.jpg)
![Page 32: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/32.jpg)
![Page 33: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/33.jpg)
![Page 34: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/34.jpg)
![Page 35: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/35.jpg)
![Page 36: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/36.jpg)
![Page 37: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/37.jpg)
![Page 38: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/38.jpg)
![Page 39: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/39.jpg)
NCI Support for Development of BRB-ArrayTools
![Page 40: Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute Richard Simon,](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d255503460f949fbd67/html5/thumbnails/40.jpg)
Possible Reasons for the Success of BRB Array Tools
• It wasn’t designed by committee• It wasn’t a response to user’s dictating what should be
developed. Few of our 6000 users really know what they needed, although most probably think that they do
• It wasn’t developed in response to management decision of what was needed
• It offers substance, not pro-forma software engineering• It offers correct approaches to data analysis in contrast
to the vast majority of commercial and free software available